Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)10

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)8

Views

Views
December 20231
January 20241
February 20240
March 20241
April 20240
May 20245
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
 

Top cities views

Views
Chicago4
Boardman2